BindingDB logo
myBDB logout

23 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
26233801 1 Synthesis and structure-activity relationship of uracil nucleotide derivatives towards the identification of human P2Y6 receptor antagonists.EBI Bar Ilan University
24712832 66 4-Alkyloxyimino derivatives of uridine-5'-triphosphate: distal modification of potent agonists as a strategy for molecular probes of P2Y2, P2Y4, and P2Y6 receptors.EBI National Institute of Diabetes and Digestive and Kidney Diseases
23368907 62 Discovery of 2-(phenoxypyridine)-3-phenylureas as small molecule P2Y1 antagonists.EBI Bristol-Myers Squibb Research and Development
22901672 15 UDP made a highly promising stable, potent, and selective P2Y6-receptor agonist upon introduction of a boranophosphate moiety.EBI Bar-Ilan University
21207957 163 Discovery of potent competitive antagonists and positive modulators of the P2X2 receptor.EBI University of Bonn
20095577 25 5-OMe-UDP is a potent and selective P2Y(6)-receptor agonist.EBI Bar-Ilan University
19902968 55 Human P2Y(14) receptor agonists: truncation of the hexose moiety of uridine-5'-diphosphoglucose and its replacement with alkyl and aryl groups.EBI National Institute of Diabetes and Digestive and Kidney Diseases
18630897 36 Selective nucleoside triphosphate diphosphohydrolase-2 (NTPDase2) inhibitors: nucleotide mimetics derived from uridine-5'-carboxamide.EBI University of Bonn
18514530 100 Synthesis and potency of novel uracil nucleotides and derivatives as P2Y2 and P2Y6 receptor agonists.EBI NIDDK
18232657 67 Lipophilic modifications to dinucleoside polyphosphates and nucleotides that confer antagonist properties at the platelet P2Y12 receptor.EBI Inspire Pharmaceuticals, Inc.
17011188 45 Novel nucleotide triphosphates as potent P2Y2 agonists.EBI UCB-Group
17302398 33 Molecular modeling of the human P2Y2 receptor and design of a selective agonist, 2'-amino-2'-deoxy-2-thiouridine 5'-triphosphate.EBI National Institute of Diabetes and Digestive and Kidney Diseases
17125260 69 Synthesis and structure-activity relationships of uracil nucleotide derivatives and analogues as agonists at human P2Y2, P2Y4, and P2Y6 receptors.EBI University of Bonn
16942026 27 Structure-activity relationships of uridine 5'-diphosphate analogues at the human P2Y6 receptor.EBI National Institute of Diabetes and Digestive and Kidney Diseases
12213051 207 Purine and pyrimidine (P2) receptors as drug targets.EBI National Institute of Diabetes
11754592 21 Methanocarba modification of uracil and adenine nucleotides: high potency of Northern ring conformation at P2Y1, P2Y2, P2Y4, and P2Y11 but not P2Y6 receptors.EBI National Institute of Diabetes
11206448 21 Synthesis and P2Y receptor activity of a series of uridine dinucleoside 5'-polyphosphates.EBI Inspire Pharmaceuticals, Inc.
21528910 87 Pyrimidine nucleotides with 4-alkyloxyimino and terminal tetraphosphated-ester modifications as selective agonists of the P2Y(4) receptor.EBI NIDDK
21417463 80 Structural modifications of UMP, UDP, and UTP leading to subtype-selective agonists for P2Y2, P2Y4, and P2Y6 receptors.EBI University of Bonn
20446735 59 Pyrimidine ribonucleotides with enhanced selectivity as P2Y(6) receptor agonists: novel 4-alkyloxyimino, (S)-methanocarba, and 5'-triphosphate gamma-ester modifications.EBI National Institute of Diabetes and Digestive and Kidney Diseases
19419868 7 Synthesis and P2Y receptor activity of nucleoside 5'-phosphonate derivatives.EBI Ghent University
16366591 3 Human P2Y(6) receptor: molecular modeling leads to the rational design of a novel agonist based on a unique conformational preference.EBI NIDDK